These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1820911)

  • 1. In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.
    Cadorniga R; Burgos ML; Negro S; Nernanez MT; Pastoriza P; Molina IT
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():379-84. PubMed ID: 1820911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of in vitro release models in formulation development and quality control of parenteral depots.
    Larsen C; Larsen SW; Jensen H; Yaghmur A; Ostergaard J
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1283-95. PubMed ID: 19941410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution kinetics of bezafibrate in two solid forms for oral administration.
    Cadorniga R; Hernanez MT; Negro S; Burgos ML; Molina IT
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():371-8. PubMed ID: 1820910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
    Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
    Gido C; Langguth P; Kreuter J; Winter G; Woog H; Mutschler E
    Pharmazie; 1993 Oct; 48(10):764-9. PubMed ID: 8265710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability].
    Dzhabarova VI; Dobrotvorskiĭ AE; Krotov AI
    Med Parazitol (Mosk); 1989; (5):43-6. PubMed ID: 2615711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A technical feasibility study of surfactant-free drug suspensions using octenyl succinate-modified starches.
    Kuentz M; Egloff P; Röthlisberger D
    Eur J Pharm Biopharm; 2006 May; 63(1):37-43. PubMed ID: 16356701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictions of in vivo plasma concentrations from in vitro release kinetics: application to doxepin parenteral (i.m.) suspensions in lipophilic vehicles in dogs.
    Gido C; Langguth P; Mutschler E
    Pharm Res; 1994 Jun; 11(6):800-8. PubMed ID: 7937517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies.
    Alighieri T; Avanessian S; Berlini S; Bianchi SG; Deluigi P; Valducci R; Guelen PJ
    Arzneimittelforschung; 1988 Jan; 38(1):92-4. PubMed ID: 3365281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamterene.
    Arias MJ; Gines JM; Moyano JR; Rabasco AM
    J Drug Target; 1994; 2(1):45-51. PubMed ID: 8069583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an in vitro absorption model system for predicting sustained release of verapamil.
    Neubert R; Fahr F; Mäder C; Lücke L; Fries G; Rostock G
    Arzneimittelforschung; 1992 Sep; 42(9):1098-100. PubMed ID: 1445475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation.
    El-Gibaly I; Abdel-Ghaffar SK
    Int J Pharm; 2005 Apr; 294(1-2):33-51. PubMed ID: 15814229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing biorelevant dissolution tests for lipid formulations: case example--lipid suspension of RZ-50.
    Jantratid E; Janssen N; Chokshi H; Tang K; Dressman JB
    Eur J Pharm Biopharm; 2008 Jun; 69(2):776-85. PubMed ID: 18226882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.